Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Loncastuximab tesirine (ADC) (DHD10899)

Applications:Research Grade Biosimilar
Overview

Catalog No.

DHD10899

Description

Loncastuximab tesirine is an ADC consisting of a CD19-directed antibody and Tesirine that induces cell apoptosis and is used for the study of diffuse B cell lymphoma and non-Hodgkin's lymphoma.

Species reactivity

Human

Clonality

Monoclonal

Target

CD19

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SEC.

Purification

Purified by Ion Exchange Chromatography.

Applications

Research Grade Biosimilar

Form

Liquid

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

ZYNLONTA

Clone ID

Loncastuximab tesirine

Data Image
References
Datasheet

Document Download

Loncastuximab tesirine (ADC).pdf

 

$ 2540
Product specifications
1 mg 2540 5 mg 6360

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Loncastuximab tesirine (ADC) [DHD10899]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only